Biography and Research Information
OverviewAI-generated summary
Dane A. Jester's research focuses on ophthalmology and the metabolic factors influencing patient outcomes. He has investigated the relationship between glycemic thresholds and the success of cataract surgery, as well as the risks of systemic health events and mortality following vitrectomy for diabetic retinopathy in patients with Type 2 diabetes. Jester has also examined visual recovery and treatment responses in cases of unexplained vision loss after silicone oil removal, including the efficacy of intensive steroid treatment. His work includes studies on pediatric acute megakaryoblastic leukemia, specifically the role of MED12L in resistance to CDK8 inhibitors. Jester has published on the outcomes of abstracts presented at the American Society of Retina Specialists meetings. His scholarship metrics include an h-index of 3 with 6 total publications and 664 citations. Key collaborators include Ahmed F. Shakarchi, Zain S Hussain, Samrat Roy Choudhury, and Jordan T. Bird, all from the University of Arkansas for Medical Sciences.
Metrics
- h-index: 3
- Publications: 6
- Citations: 688
Selected Publications
-
Pars Plana Vitrectomy, Glycemic Control, and Systemic Adverse Events in Patients With Diabetes Mellitus: A Retrospective Cohort Study (2026)
-
Publication Outcomes of Abstracts Presented at Meetings of the American Society of Retina Specialists (2025)
-
Risk of Systemic Health Events and Mortality After Vitrectomy for Diabetic Retinopathy in Patients with Type 2 Diabetes (2025)
-
Is There a Safe Glycemic Threshold for Cataract Surgery? (2025)
-
Epigenetically Enhanced MED12L in ETO2-GLIS2 Positive Pediatric Acute Megakaryoblastic Leukemia Is Associated with Resistance to the CDK8 Inhibitors (2021)
Collaboration Network
Top Collaborators
- Is There a Safe Glycemic Threshold for Cataract Surgery?
- Publication Outcomes of Abstracts Presented at Meetings of the American Society of Retina Specialists
- Risk of Systemic Health Events and Mortality After Vitrectomy for Diabetic Retinopathy in Patients with Type 2 Diabetes
- Is There a Safe Glycemic Threshold for Cataract Surgery?
- Publication Outcomes of Abstracts Presented at Meetings of the American Society of Retina Specialists
- Risk of Systemic Health Events and Mortality After Vitrectomy for Diabetic Retinopathy in Patients with Type 2 Diabetes
- Is There a Safe Glycemic Threshold for Cataract Surgery?
- Publication Outcomes of Abstracts Presented at Meetings of the American Society of Retina Specialists
- Risk of Systemic Health Events and Mortality After Vitrectomy for Diabetic Retinopathy in Patients with Type 2 Diabetes
- Is There a Safe Glycemic Threshold for Cataract Surgery?
- Risk of Systemic Health Events and Mortality After Vitrectomy for Diabetic Retinopathy in Patients with Type 2 Diabetes
- Epigenetically Enhanced MED12L in ETO2-GLIS2 Positive Pediatric Acute Megakaryoblastic Leukemia Is Associated with Resistance to the CDK8 Inhibitors
- Epigenetically Enhanced MED12L in ETO2-GLIS2 Positive Pediatric Acute Megakaryoblastic Leukemia Is Associated with Resistance to the CDK8 Inhibitors
- Epigenetically Enhanced MED12L in ETO2-GLIS2 Positive Pediatric Acute Megakaryoblastic Leukemia Is Associated with Resistance to the CDK8 Inhibitors
- Epigenetically Enhanced MED12L in ETO2-GLIS2 Positive Pediatric Acute Megakaryoblastic Leukemia Is Associated with Resistance to the CDK8 Inhibitors
- Epigenetically Enhanced MED12L in ETO2-GLIS2 Positive Pediatric Acute Megakaryoblastic Leukemia Is Associated with Resistance to the CDK8 Inhibitors
- Epigenetically Enhanced MED12L in ETO2-GLIS2 Positive Pediatric Acute Megakaryoblastic Leukemia Is Associated with Resistance to the CDK8 Inhibitors
- Epigenetically Enhanced MED12L in ETO2-GLIS2 Positive Pediatric Acute Megakaryoblastic Leukemia Is Associated with Resistance to the CDK8 Inhibitors
- Epigenetically Enhanced MED12L in ETO2-GLIS2 Positive Pediatric Acute Megakaryoblastic Leukemia Is Associated with Resistance to the CDK8 Inhibitors
- Epigenetically Enhanced MED12L in ETO2-GLIS2 Positive Pediatric Acute Megakaryoblastic Leukemia Is Associated with Resistance to the CDK8 Inhibitors
- Epigenetically Enhanced MED12L in ETO2-GLIS2 Positive Pediatric Acute Megakaryoblastic Leukemia Is Associated with Resistance to the CDK8 Inhibitors
- Is There a Safe Glycemic Threshold for Cataract Surgery?
Similar Researchers
Based on overlapping research topics